Retatrutide's Phase 3 trials started in 2024, putting a 2027 to 2028 approval in line with that trajectory
PlexusDx sources all compounded medications from licensed 503A compounding pharmacies, which follow rigorous FDA quality standards for preparation and sterility
The FDA has previously approved an oral medication from the same drug class for the treatment of diabetes, but the new decision allows doctors to prescribe the therapy specifically for weight loss
6a and Supplementary Fig
Convenience is not worth a quality shortcut on a compound you are injecting
Overall, the benefits of using a peptide supplied in a vial for scientific investigations include better storage capabilities, precision of dosing, and experimental adaptability, all of which contribute to the quality, accuracy, and efficacy of research findings towards peptide therapies